BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 17636305)

  • 1. Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads.
    Furushima H; Chinushi M; Okamura K; Iijima K; Komura S; Tanabe Y; Okada S; Izumi D; Aizawa Y
    Europace; 2007 Oct; 9(10):951-6. PubMed ID: 17636305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of late potentials for 24 hours between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy using a novel signal-averaging system based on Holter ECG.
    Abe A; Kobayashi K; Yuzawa H; Sato H; Fukunaga S; Fujino T; Okano Y; Yamazaki J; Miwa Y; Yoshino H; Ikeda T
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):789-95. PubMed ID: 22665699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
    Doi A; Takagi M; Maeda K; Tatsumi H; Shimeno K; Yoshiyama M
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):688-96. PubMed ID: 20050961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between dominant prolongation of the filtered QRS duration in the right precordial leads and clinical characteristics in Brugada syndrome.
    Furushima H; Chinushi M; Hirono T; Sugiura H; Watanabe H; Komura S; Washizuka T; Aizawa Y
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1311-7. PubMed ID: 16403063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of T(peak) -T(end) interval to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic right ventricular outflow tract tachycardia.
    Golcuk E; Yalin K; Kaya Bilge A; Elitok A; Aksu T; Akgun T; Bilal Karaayvaz E; Emet S; Adalet K
    Pacing Clin Electrophysiol; 2014 Dec; 37(12):1665-70. PubMed ID: 25041179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of different electrocardiographic depolarization criteria in the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Peters S; Trümmel M; Koehler B; Westermann KU
    J Electrocardiol; 2007 Jan; 40(1):34-7. PubMed ID: 17118392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Basso C; Leoni L; Tokajuk B; Bauce B; Frigo G; Tarantini G; Napodano M; Turrini P; Ramondo A; Daliento L; Nava A; Buja G; Iliceto S; Thiene G
    Circulation; 2005 Jun; 111(23):3042-50. PubMed ID: 15939822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biventricular myocardial strain analysis using cardiac magnetic resonance feature tracking (CMR-FT) in patients with distinct types of right ventricular diseases comparing arrhythmogenic right ventricular cardiomyopathy (ARVC), right ventricular outflow-tract tachycardia (RVOT-VT), and Brugada syndrome (BrS).
    Heermann P; Fritsch H; Koopmann M; Sporns P; Paul M; Heindel W; Schulze-Bahr E; Schülke C
    Clin Res Cardiol; 2019 Oct; 108(10):1147-1162. PubMed ID: 30868222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intraatrial conduction abnormality assessed by P-wave signal-averaged electrocardiogram in patients with Brugada syndrome.
    Furukawa Y; Yamada T; Okuyama Y; Morita T; Tanaka K; Iwasaki Y; Ueda H; Okada T; Kawasaki M; Kuramoto Y; Fukunami M
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1138-46. PubMed ID: 21605130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive diagnosis of electroanatomic abnormalities in arrhythmogenic right ventricular cardiomyopathy.
    Santangeli P; Pieroni M; Dello Russo A; Casella M; Pelargonio G; Macchione A; Camporeale A; Smaldone C; Bartoletti S; Di Biase L; Bellocci F; Natale A
    Circ Arrhythm Electrophysiol; 2010 Dec; 3(6):632-8. PubMed ID: 20937720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy.
    Quarta G; Ward D; Tomé Esteban MT; Pantazis A; Elliott PM; Volpe M; Autore C; McKenna WJ
    Heart; 2010 Apr; 96(7):516-22. PubMed ID: 20350987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epsilon-like waves and ventricular conduction abnormalities in subjects with type 1 ECG pattern of Brugada syndrome.
    Letsas KP; Efremidis M; Weber R; Korantzopoulos P; Protonotarios N; Prappa E; Kounas SP; Evagelidou EN; Xydonas S; Kalusche D; Sideris A; Arentz T
    Heart Rhythm; 2011 Jun; 8(6):874-8. PubMed ID: 21315837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome.
    Morita H; Kusano KF; Miura D; Nagase S; Nakamura K; Morita ST; Ohe T; Zipes DP; Wu J
    Circulation; 2008 Oct; 118(17):1697-704. PubMed ID: 18838563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
    Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y
    Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction.
    Sarvari SI; Haugaa KH; Anfinsen OG; Leren TP; Smiseth OA; Kongsgaard E; Amlie JP; Edvardsen T
    Eur Heart J; 2011 May; 32(9):1089-96. PubMed ID: 21406439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late potential at the high ventricular septal level in a patient with Brugada: possible mechanisms and clinical implications.
    Baez-Escudero JL; Shah DP; Weisberg IL; Beshai JF; Burke MC
    J Electrocardiol; 2010; 43(5):459-62. PubMed ID: 20728020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach for the comparison of conduction abnormality between arrhythmogenic right ventricular cardiomyopathy/dysplasia and Brugada syndrome.
    Yodogawa K; Morita N; Kobayashi Y; Takayama H; Ohara T; Seino Y; Katoh T; Mizuno K
    Ann Noninvasive Electrocardiol; 2011 Jul; 16(3):263-9. PubMed ID: 21762254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of early onset and progressive increase of activation delay during premature stimulation in Brugada syndrome.
    Furushima H; Chinushi M; Iijima K; Izumi D; Hosaka Y; Aizawa Y
    Circ J; 2009 Aug; 73(8):1408-15. PubMed ID: 19531898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy: correlation to the QRS dispersion.
    Ma N; Cheng H; Lu M; Jiang S; Yin G; Zhao S
    Magn Reson Imaging; 2012 Dec; 30(10):1454-60. PubMed ID: 22819580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic ventricular repolarization during cardiovascular autonomic function testing in patients with arrhythmogenic right ventricular cardiomyopathy.
    Haapalahti P; Viitasalo M; Kaartinen M; Väänänen H; Oikarinen L; Heliö T; Toivonen L
    Scand Cardiovasc J; 2008 Dec; 42(6):375-82. PubMed ID: 18615356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.